James Krueger is a Dermatology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1230 York Ave
New York, NY 100656307
Telephone
212-327-8091Registry record last updated 27 Sept 2010.
Clinical trials
- Safety and Efficacy of Secukinumab in Mild Psoriasis
Sponsor: James G. Krueger, MD, PhD
- Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis
Sponsor: Rockefeller University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20256 payments$14,709openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20253 payments$14,125openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
9 NIH research awards on record, funded 1992–2025 per NIH RePORTER. The latest:
- Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
Rockefeller University
FY2025$3,671,021UL1TR001866 - Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
Rockefeller University
FY2024$3,669,160UL1TR001866 - Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
Rockefeller University
FY2023$2,775,381UL1TR001866
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”